Physician profile
Halsey M Settle
NPI 1962404269
$2,365.30
in general payments reported to CMS, 2019-2025
19 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $227 · 2021: $568 · 2022: $455 · 2023: $333 · 2024: $258 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $544.57 | 2019-2022 | |
| Abbvie INC. | $417.68 | 2022-2025 | Durysta, Lumigan |
| Sun Pharmaceutical Industries INC. | $214.62 | 2020-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $194.73 | 2019-2023 | |
| Alcon Vision LLC | $176.30 | 2019-2025 | Tryptyr, Rocklatan |
| Bausch & Lomb Americas INC. | $141.61 | 2023-2025 | Miebo, Xiidra, Doctors Allergy Formula |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.58 | 2019-2021 | |
| Biotissue Holdings INC. | $83.15 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $69.74 | 2019-2021 | |
| Thea Pharma INC. | $64.82 | 2022-2025 | Iyuzeh |
| Harrow Eye, LLC | $60.27 | 2024-2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $53.32 | 2019-2021 | |
| Oyster Point Pharma, INC. | $52.40 | 2022-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $45.89 | 2024 | Xdemvy |
| Shire North American Group INC | $40.84 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $34.90 | 2024-2025 | Tepezza |
| Rxsight INC | $20.69 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Horizon Therapeutics Plc | $19.09 | 2023 | Tepezza |
| Tearlab Corp | $17.10 | 2024 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Halsey Settle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.